SHIONOGI + CO. LTD/ JP3347200002 /
9/20/2024 9:39:24 PM | Chg. +0.4000 | Volume | Bid9:39:25 PM | Ask9:54:28 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
40.0000EUR | +1.01% | 0 Turnover: 0.0000 |
-Bid Size: - | -Ask Size: - | 11.34 bill.EUR | - | - |
GlobeNewswire
5/23
Apnimed Announces a Robust Slate of Presentations at SLEEP 2024, Including an Analysis of the Preval...
GlobeNewswire
5/9
Apnimed Announces Completion of Enrollment in Phase 3 LunAIRo Study of AD109, the Potential First Ni...
GlobeNewswire
3/6
Apnimed to Participate in the Upcoming Leerink Partners Global Biopharma Conference
GlobeNewswire
2/22
Apnimed to Participate in the Upcoming Evercore ISI 2024 Emerging Biotech Conference
GlobeNewswire
2/7
Alleo Labs Announces Publication on the Use of Artificial Intelligence in Neuroscience Drug Discover...
GlobeNewswire
1/22
Apnimed Announces New Leadership Appointments as the Company Builds Its Commercial and Human Resourc...
GlobeNewswire
11/10/2023
Sosei Heptares Operational Highlights and Consolidated Results for the Third Quarter and First Nine ...
GlobeNewswire
11/1/2023
Apnimed Announces Launch of Joint Venture with Shionogi to Develop Novel Pharmacologic Therapies for...
GlobeNewswire
10/21/2023
F2G and Shionogi Present Full Data Set from Pivotal Phase 2b Study at Trends in Medical Mycology (TI...
GlobeNewswire
9/20/2023
OnKure Therapeutics Appoints Ann Howell, Pharm.D., as Vice President of Regulatory Affairs
GlobeNewswire
12/22/2021
Zai Lab Announces Promotion of Harald Reinhart, M.D. to President and Head of Global Development, Ne...
GlobeNewswire
11/4/2021
Arcutis Announces Third Quarter 2021 Financial Results and Provides Business Update
GlobeNewswire
5/13/2021
Metacrine Accelerates MET409 Clinical Development Milestone and Reports First-Quarter 2021 Results
GlobeNewswire
4/27/2021
InveniAI and Shionogi Enter AI-Powered Multi-Target Drug Discovery Collaboration
GlobeNewswire
10/30/2020
BioFlorida Names AIM ImmunoTech CEO Thomas K. Equels as Entrepreneur of the Year